Search research articles
Contact Us
Filters
Showing results (661-670 of 957) with videos related to
Page
of 96
Sort By:
Brain : a Journal of Neurology
|
February 15, 2023
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R Jack, Heather J Wiste, Alicia Algeciras-Schimnich, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Brain-derived extracellular vesicle microRNAs in Lewy body and Alzheimer's disease
Stephanie J Yang, Andrew A Lin, Hanfei Shen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 5, 2024
Missense and loss-of-function variants at GWAS loci in familial Alzheimer's disease
Tamil Iniyan Gunasekaran, Dolly Reyes-Dumeyer, Kelley M Faber, et al.
Neuroimage
|
October 9, 2020
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
Petrice M Cogswell, Heather J Wiste, Matthew L Senjem, et al.
Neurology
|
November 28, 2022
Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies
Daniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Neurology
|
August 26, 2018
<i>APOE</i> ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology
Dennis W Dickson, Michael G Heckman, Melissa E Murray, et al.
Neurology
|
February 18, 2011
Classification of primary progressive aphasia and its variants
M L Gorno-Tempini, A E Hillis, S Weintraub, et al.
Annals of Clinical and Translational Neurology
|
October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Peter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Neurology
|
February 19, 2017
Polygenic risk scores in familial Alzheimer disease
Giuseppe Tosto, Thomas D Bird, Debby Tsuang, et al.
Neurology
|
August 19, 2011
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
T J Ferman, B F Boeve, G E Smith, et al.
Page
of 96
Search research articles
Search
Showing results (661-670 of 957) with videos related to
Sort By:
Page
of 96
Brain : a Journal of Neurology
|
February 15, 2023
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R Jack, Heather J Wiste, Alicia Algeciras-Schimnich, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
Brain-derived extracellular vesicle microRNAs in Lewy body and Alzheimer's disease
Stephanie J Yang, Andrew A Lin, Hanfei Shen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 5, 2024
Missense and loss-of-function variants at GWAS loci in familial Alzheimer's disease
Tamil Iniyan Gunasekaran, Dolly Reyes-Dumeyer, Kelley M Faber, et al.
Neuroimage
|
October 9, 2020
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
Petrice M Cogswell, Heather J Wiste, Matthew L Senjem, et al.
Neurology
|
November 28, 2022
Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies
Daniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Neurology
|
August 26, 2018
<i>APOE</i> ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology
Dennis W Dickson, Michael G Heckman, Melissa E Murray, et al.
Neurology
|
February 18, 2011
Classification of primary progressive aphasia and its variants
M L Gorno-Tempini, A E Hillis, S Weintraub, et al.
Annals of Clinical and Translational Neurology
|
October 24, 2018
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Peter A Ljubenkov, Adam M Staffaroni, Julio C Rojas, et al.
Neurology
|
February 19, 2017
Polygenic risk scores in familial Alzheimer disease
Giuseppe Tosto, Thomas D Bird, Debby Tsuang, et al.
Neurology
|
August 19, 2011
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
T J Ferman, B F Boeve, G E Smith, et al.
Page
of 96